FDA Receives Alcon, Inc. Clearance To Implement Corrective Action Plan to Correct Malfunctions For Constellation Vision System

Ortho Super Site -- HUENENBERG, Switzerland — The U.S. Food and Drug Administration has cleared Alcon’s 510(k) submission to complete its voluntary medical device corrective action plan for its Constellation Vision System, the company announced in a press release.